Tokyo Tape
Sign in
← Wakamoto Pharmaceutical

Quarterly report · Q2

4512.TEDINET S100PMDQ
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥4.0bn2022-04-01 → 2022-09-30StandaloneNet sales
Revenue¥8.4bn2021-04-01 → 2022-03-31StandaloneNet sales (5-year summary)
Revenue¥4.0bn2021-04-01 → 2021-09-30StandaloneNet sales
Operating income−¥86m2022-04-01 → 2022-09-30StandaloneOperating income
Operating income−¥172m2021-04-01 → 2021-09-30StandaloneOperating income
Ordinary income−¥28m2022-04-01 → 2022-09-30StandaloneOrdinary income
Ordinary income¥72m2021-04-01 → 2022-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥154m2021-04-01 → 2021-09-30StandaloneOrdinary income
Profit before tax−¥28m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax¥59m2021-04-01 → 2021-09-30StandaloneIncome before income taxes
Net income−¥22m2022-04-01 → 2022-09-30StandaloneProfit loss
Net income¥239m2021-04-01 → 2022-03-31StandaloneNet income loss (5-year summary)
Net income¥112m2021-04-01 → 2021-09-30StandaloneProfit loss
Total assets¥14.7bnat 2022-09-30StandaloneAssets
Total assets¥15.0bnat 2022-03-31StandaloneAssets
Total assets¥14.7bnat 2021-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.2bnat 2022-09-30StandaloneLiabilities
Total liabilities¥3.5bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥11.6bnat 2022-09-30StandaloneNet assets
Net assets / equity¥11.5bnat 2022-03-31StandaloneNet assets
Net assets / equity¥11.3bnat 2021-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥3.6bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥3.2bnat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥3.6bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥3.3bnat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥2.8bnat 2021-03-31dStandaloneCash and cash equivalents
Operating cash flow¥254m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥339m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥169m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥150m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥51m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥286m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥1m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥2m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-0.622022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-0.482022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥6.872021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥3.222021-04-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥1.942021-07-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio78.6%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio76.8%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio76.9%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued34,838,000at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued34,838,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued34,838,000at 2021-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥2.1bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.1bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30−¥205m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥949m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥949m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥45m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥850m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥850m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥37m
—segment totalrevenue2022-04-01 → 2022-09-30¥4.0bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥4.0bn
—segment totalsegment profit2022-04-01 → 2022-09-30−¥86m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥4.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30−¥86m
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue2021-04-01 → 2021-09-30¥2.2bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue external2021-04-01 → 2021-09-30¥2.2bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentsegment profit2021-04-01 → 2021-09-30−¥157m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue2021-04-01 → 2021-09-30¥783m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue external2021-04-01 → 2021-09-30¥783m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentsegment profit2021-04-01 → 2021-09-30¥66m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue2021-04-01 → 2021-09-30¥969m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue external2021-04-01 → 2021-09-30¥969m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentsegment profit2021-04-01 → 2021-09-30−¥96m
—segment totalrevenue2021-04-01 → 2021-09-30¥4.0bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥4.0bn
—segment totalsegment profit2021-04-01 → 2021-09-30−¥172m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥4.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30−¥172m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 537
ItemContextValueUnit
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000OtcProductsBusinessRelatedReportableSegmentsMember850022000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000GlobalSalesDevelopmentBusinessRelatedReportableSegmentsMember949017000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000RealEstateLeasingBusinessMember89335000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember4019650000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember4019650000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember4019650000JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000EthicalProductsBusinessRelatedReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000OtcProductsBusinessRelatedReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000GlobalSalesDevelopmentBusinessRelatedReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000RealEstateLeasingBusinessMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000EthicalProductsBusinessRelatedReportableSegmentsMember2131274000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000OtcProductsBusinessRelatedReportableSegmentsMember850022000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000GlobalSalesDevelopmentBusinessRelatedReportableSegmentsMember949017000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000RealEstateLeasingBusinessMember89335000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember4019650000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember4019650000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember4019650000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000EthicalProductsBusinessRelatedReportableSegmentsMember-205013000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000OtcProductsBusinessRelatedReportableSegmentsMember36972000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000GlobalSalesDevelopmentBusinessRelatedReportableSegmentsMember44908000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000RealEstateLeasingBusinessMember37188000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember-85944000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember-85944000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-85944000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-11-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第128期第２四半期（自　2022年７月１日　至　2022年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)わかもと製薬株式会社
Company name in english cover pageFilingDateInstantWAKAMOTO PHARMACEUTICAL CO.,LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　五十嵐　新
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋本町二丁目２番２号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)（０３）３２７９－０３７１（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)広報室長　　福原　和彦
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋本町二丁目２番２号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)（０３）３２７９－０３７１（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)広報室長　　福原　和彦
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00928
Fund codeFilingDateInstant－
Security codeFilingDateInstant45120
Filer name in japaneseFilingDateInstant
Original text (Japanese)わかもと製薬株式会社

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-03-31pass
balance sheet identitynon_consolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass